Related Experiment Video
Updated: Jul 3, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Induction of apoptosis by phenethyl isothiocyanate in cells overexpressing Bcl-XL
Sarah L Cuddihy1, Kristin K Brown, Susan J Thomson
1Free Radical Research Group, Department of Pathology, University of Otago, PO Box 4345, Christchurch, New Zealand. sarah.cuddihy@otago.ac.nz
Abstract:
Isothiocyanates are a class of phytochemicals able to induce apoptosis in numerous cells including Jurkat T-lymphoma cells overexpressing the oncoprotein Bcl-2. To test if isothiocyanates are also effective against other anti-apoptotic members of the Bcl-2 family we generated Jurkat cells stably overexpressing Bcl-X(L). Phenethyl isothiocyanate (PEITC) was cytotoxic to these cells, with an LD(50) ranging from 9 to 18 microM depending on the level of Bcl-X(L) expression. Apoptosis induction in response to PEITC was confirmed by caspase activation and phosphatidylserine exposure. Isothiocyanates specifically target cysteine residues, therefore we tested the hypothesis that PEITC directly impairs Bcl-2 and Bcl-X(L) activity by interacting with their conserved cysteine residues. Jurkat cells overexpressing double cysteine mutants of Bcl-2 were generated, but they remained sensitive to PEITC. We conclude that PEITC antagonizes the action of anti-apoptotic Bcl-2 family members via an indirect mechanism.
Insights
Phenethyl isothiocyanate (PEITC) induces apoptosis in cancer cells by indirectly targeting anti-apoptotic Bcl-2 family proteins. This phytochemical shows cytotoxicity against Jurkat cells overexpressing Bcl-X(L).
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Isothiocyanates are phytochemicals known to induce apoptosis, programmed cell death, in various cancer cells.
- The Bcl-2 family of proteins, including Bcl-2 and Bcl-X(L), are key regulators of apoptosis, often overexpressed in cancer to promote cell survival.
- Previous studies show isothiocyanates are effective against Jurkat T-lymphoma cells overexpressing Bcl-2.
Purpose of the Study:
- To investigate the efficacy of isothiocyanates, specifically phenethyl isothiocyanate (PEITC), against other anti-apoptotic members of the Bcl-2 family.
- To determine if PEITC directly interacts with conserved cysteine residues in Bcl-2 and Bcl-X(L) to impair their function.
- To elucidate the mechanism by which PEITC antagonizes anti-apoptotic Bcl-2 family members.
Main Methods:
- Generation of Jurkat cells stably overexpressing Bcl-X(L).
- Assessment of PEITC cytotoxicity using LD(50) determination.
- Confirmation of apoptosis induction via caspase activation and phosphatidylserine exposure assays.
- Creation and testing of Jurkat cells overexpressing double cysteine mutants of Bcl-2.
Main Results:
- PEITC demonstrated cytotoxicity against Jurkat cells overexpressing Bcl-X(L), with LD(50) values ranging from 9 to 18 microM.
- Apoptosis induction by PEITC was confirmed through caspase activation and phosphatidylserine exposure.
- Jurkat cells overexpressing Bcl-2 cysteine mutants remained sensitive to PEITC, indicating no direct interaction with these residues.
Conclusions:
- PEITC effectively induces apoptosis in cancer cells expressing anti-apoptotic Bcl-2 family proteins like Bcl-X(L).
- The mechanism of PEITC's action against Bcl-2 family proteins is indirect, not involving direct interaction with their conserved cysteine residues.
- PEITC represents a potential therapeutic agent for cancers characterized by the overexpression of anti-apoptotic Bcl-2 family members.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
